Tech Company Financing Transactions
EnsiliTech Funding Round
Calculus Capital, Eos Advisory and Empirical Ventures participated in a $6 million Seed funding round for EnsiliTech. The round closed on 8/28/2025.
Transaction Overview
Company Name
Announced On
8/28/2025
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Seed
Investors
Calculus Capital (Lead Investor)
Eos Advisory (Lead Investor)
Proceeds Purpose
The company intends to use the funds to accelerate its growth and further enhance its infrastructure capabilities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Science Creates Albert Road, Saint Philips Central
Bristol England, BS2 0XJ
UK
Bristol England, BS2 0XJ
UK
Phone
Undisclosed
Website
Email Address
Overview
Our novel ensilication technology exploits the growth of protective silica nanoshells on the surface of vaccine components, to prevent degradation which can lead to vaccine spoilage. Once applied, our vaccines can be stored and transported without the need for cold chain infrastructure, preventing wastage, improving shelf-life and increasing vaccine accessibility globally.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Asel Sartbaeva
Chief Technical Officer
Aswin Doekhie
Co-Founder
Matt Slade
Browse more venture capital transactions:
Prev: 8/28/2025: Ordinal venture capital transaction
Next: 8/28/2025: FinChain venture capital transaction
Share this article
News on VC Transactions
We do our best to document every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs